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The last years' research has provided considerable insight into the pathogenesis of 
cholera at  the molecular level.  The choleragenic agent  has  been  identified  to be  a 
protein exotoxin of mol wt 84,000 which has been isolated and crystallized (1-3). Its 
toxic action seems to reside in its capacity to activate the adenylate cyclase system in 
the small bowel mucosa; in fact this ability is not restricted to intestinal cells but has 
been found with all mammalian cell types tested (4, 5). 
Lymphocytes are particularly interesting cells to study with regard to events which 
relate  initial  surface binding of agents  to cellular  activation  or deactivation.  Such 
processes are involved in the action of specific antigens or mitogenic lectins. Recently 
a  role  of  cyclic 3'5'-adenosine monophosphate  (c-AMP)  has  been  proposed  for in 
vitro hypersensitivity reactions of immediate as well as delayed type (6, 7). A study 
of  interactions  between  the  potent  adenylate  cyclase  activator  cholera  toxin  and 
lymphocytes might  therefore  give  information  which  could  elucidate  certain  im- 
portant  aspects  of lymphocyte function.  Reports published  during  the progress  of 
our study showing that lymphocytes respond to cholera toxin with a  rise  in c-AMP 
(8, 9) were consistent with this assumption. 
It  has  recently been  shown  that  the  ganglioside  GM1 in  all  likelihood  con- 
stitutes the cell membrane receptor for the cholera toxin (10-13). This ganglio- 
side seems to bind the toxin to the cell surface through the structure galactose 
/31-3-N-acetylgalactosamine  /~1-4  (N-acetylneuraminic  acid  [~2-3])  galactose 
/31-(11).  It is also known that the toxin consists of two different types of sub- 
units,  heavy (H) 1 and light  (L)  (14).  The available  evidence suggests that the 
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intact toxin is built up by the noncovalent aggregation of  one H  chain and 
several, perhaps six or seven L  chains. It is not well understood how the sub- 
unit arrangement of cholera toxin determines the biologic activity. It appears 
that the L  type of subunit is responsible for the binding of the toxin to  GM1 
receptors (11),  2' 3 but at least as tested with the rabbit intradermal assay the 
additional presence of H  subunit has been found important for the toxic activ- 
ity (14). It was the aim of the present study to test the usefulness of the well- 
characterized mouse lymphocyte as target cell for more detailed investigations 
of how the cell-binding  properties relate to the biologic action of the toxin, and 
what significance the H  and L subunits have for binding and activity. We chose 
lymphocyte stimulation by the mitogenic lectin concanavalin A  (con A),  as 
the process to study possible interference with, since it represents an established 
cellular activation model where the stimulating agent resembles cholera toxin 
by being a subunit-composed protein which binds to defined cell surface recep- 
tors (15). 
Materials and Methods 
Mammalian Cells.--Thymus  lymphocytes and spleen cells were obtained from 4-6-wk old 
CBA mice, which had been killed by cervical spine dislocation. The thymus and spleen were 
removed aseptically and cell suspensions prepared by squeezing the organs through a stain- 
less steel grid into Eagle's minimum essential medium (MEM) or phosphate buffered saline 
(PBS). Human erythrocytes were obtained from an adult male donor and suspended in PBS. 
Cholera Toxin, Toxoid, and Toxin Subunits.--Isolated  cholera toxin (choleragen) and na- 
tural toxoid (choleragenoid) were prepared by Dr. R. A. Finkelstein, Dallas, Texas (1). Dr. 
R.  Northrup distributed  the  toxin from the National Institute of Allergy and Infectious 
Diseases, Bethesda, Md.  (Lots 1071 and 0572) and Dr. Finkelstein generously provided the 
toxoid. Stock solutions were prepared and stored as earlier (14). 
Toxin was also fractionated in order to obtain samples with varying proportions of H and 
L subunits. A slight modification of a previously described fractionation procedure was used 
(14). A 200/zl sample of toxin, 5 mg/ml, was mixed with 100/zl of 1 M glycin-HC1,  pH 3.8, 
and incubated at room temperature for 30 min. It was then subjected to filtration through a 
15 X 600-mm Sephadex G-100 column using 0.1 M glycine-HC1,  pH 3.8, as eluting buffer. The 
higher pH employed in this modified fractionation procedure gave a much better yield of the 
labile H subunit but less complete separation of this subunit from L-chain material, as es- 
timated  with Lowry  protein  determinations  and sodium  dodecylsulphate  polyacrylamide 
(SDS) electrophoresis (14). The slowest filtering fraction  (no. 34) contained pure L subunit 
material as judged from SDS electrophoresis. This was verified by immunodiffusion experi- 
ments where an antiserum to toxin (see below) which contained precipitating antibodies to 
the H subunit as well as to the L subunit was used.  2,3 In SDS electrophoresis tests also frac- 
tion 33 seemed to consist only of L subunits, but the immunodiffusion test revealed trace con- 
tamination with H subunit; it contained more material than fraction 34 and was therefore 
used as purified L subunit (fraction "L"). The faster-filtering fraction 28, which was rich in 
2 Holmgren, J. Immunologic and receptor-binding properties of cholera toxin and its sub- 
units. Proceedings of the 9th U. S.-Japan Cholera Conference. U. S. Government Printing 
Office. In press. 
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H  subunit (73%), was freed from the contaminating L  subunit material by incubation in a 
series of polystyrene tubes, which had been coated with the ganglioside GM1 (16), which binds 
the L chains but not free H chains.  2'3 This procedure provided fraction "H", which contained 
pure H  subunit as shown by SDS electrophoresis and only the faintest trace of L  subunit in 
immunodiffusion analyses. Fractions with intermediate filtration rates (nos. 29-32) contained 
H  as well as L  subunits in substantial and varying proportions. The subuuit contents in the 
toxin, toxoid, and toxin fractions are shown in Table V in the Results section. 
Radioiodinated Proteins.--Cholera toxin  and  toxoid,  and  the lectin con A  (Miles-Yeda, 
Rehovot,  Israel)  were  labeled  with  125I by  the  chloramine T  method  (17).  Carrier-free 
[12~I]Na was purchased  from The  Radiochemical  Centre,  Amersham,  England.  In  a  total 
volume of 25/zl,  25 #g of protein reacted for  1 min at room temperature with 0.5 mC  of 
[125I]Na (sp act >  14 mC//~g and 25 #g of chloramine T)  (E. Merck AG, Darmstadt, West 
Germany). The reaction was  stopped  by  adding  50  /zg  sodium  metabisulphite,  and  after 
dilution with three volumes of distilled water the sample was filtered through a 5  X  50-mm 
Sephadex G-25 column. The yields of protein-bound radioactivity were approximately 10% 
for cholera toxin and toxoid, and 30% for con A.  The molar ratio of iodine to protein was 
between 1:10 and 1 : 20. 
Gangliosides and  Related Neutral Glycosphingolipids.--Dr. L.  Svennerholm,  G6teborg, 
Sweden provided a series of pure gangliosides and related neutral glycosphingolipids, including 
the GM1 ganglioside which is the likely tissue receptor for the cholera toxin. The following 
substances, prepared and characterized as reported  (11),  were used:  globoside,  GalNAc~I- 
3Galod-4Gaifll- 4Glc-Cer; GA1, Gal/~l-3GalNAc/31-4Gal/~l-4Glc-Cer; tetrahexoside-GlcNAc, 
Gal/31-4GlcNAc~l-3Gai/Jl-4Glc-Cer; GM~, NANa2-3Gal/31-4Glc-Cer and NGNo~2-3Galfll- 
4Glc-Cer;  GM2,  GaiNAc131-4(NANa2-3)Gal/31-4Glc-Cer;  GM1,  Gal/~I-3GalNAc/31-4- 
(NANa2-3)Gal/~I-4Glc-Cer;  GDla,  NANa2-3Gal/31-3GalNAc/~I-4(NANa2-3)GaI~I-4Glc- 
Cer;  GDlb,  Gal/~I-3GalNAc~I-4(NANa2-8NANo~2-3)Gai/31-4Glc-Cer;  GT1,  NANa2- 
3Gal~l-3  GalNAcfl  1-4 (NANa2-SNANa2-3) Gal~1-4Glc-Cer. 
ce-Methyl-D-Glucoside.--The  specific  oligosaccharide  inhibitor  of  con  A,  a-methyl-D- 
glucoside, was purchased from Sigma Chemical Company,  St. Louis. Mo. 
Antisera.--Antiserum  to cholera toxin was prepared in a rabbit. Three injections of 30/zg 
of toxin were given subcutaneously with intervals of 3 wk between each injection; the bleed- 
ing was taken 2 wk after the last injection. This antiserum contained precipitating antibodies 
against the L  as well as the H  subunits of the toxin as shown by double diffusion-in-gel tech- 
nique.  2,3 Rabbit antiserum to mouse immunoglobulin was purchased from Behringwerke AG, 
Marburg-Lahn, West Germany. Fluorescein isothiocyanate (FITC)-labeled sheep antiserum 
to  rabbit immunoglobulin was  obtained from  SBL,  Stockholm,  Sweden.  All antisera were 
absorbed three times with CBA mouse erythrocytes before use. 
Binding of Cholera Proteins to Cells Studied by Immunofluorescence.--Immunofluorescence 
studies of binding of cholera toxin, toxoid, and toxin subunits to mammalian cells were per- 
formed with mouse thymus lymphocytes or human erythrocytes suspended in PBS to a density 
of 107 cells/ml. To 100 #1 of cell suspension was added 100 #1 of cholera protein, when not 
otherwise stated at a concentration of 1 #g/ml. After incubation for 15 min at room tempera- 
ture the cells were washed twice with PBS, and resuspended in 100 #1 of PBS. The rabbit anti- 
cholera toxin antiserum diluted 1:4 in PBS was added in a volume of 100/zl, and 15 min later 
the cells were washed and resuspended as before. 100 #1 of FITC antirabbit immunoglobulin 
diluted 1:4 in PBS was added, and after another 15 rain at room temperature the cells were 
again washed and suspended in PBS, and 10 #1 of the cell suspension placed under a cover slip 
on a microscopic slide. Fluorescence microscopy and photography was performed with a Leitz 
fluorescence microscope equipped with a Ploem illuminator and a Leitz automatic microscope 
camera ('Leitz GMBH, Ernst Wetzlar, West Germany). 
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toxoid or con A  to mammalian cells were performed with mouse thymus lymphocytes sus- 
pended in MEM supplemented with 1% bovine serum albumin (BSA), pH 7.2, to a density 
of 5 X  107 cells/ml. 200 #1 of the cell suspension was incubated, when not otherwise stated at 
37°C for 30 rain, with [l~sI]toxin, [125I]toxoid, or [125I]conA in the presence or absence of these 
proteins nonlabeled. The cells were washed twice on Millipore EAWP filters (Millipore Corp., 
Bedford, Mass.) with cold PBS, pH 7.2, and the filter with the cells transferred to a test tube. 
The radioactivity of the tube was measured in a gamma ray spectrometer. All experiments 
were performed in triplicates and the results are expressed as mean values for bound radio- 
activity/million cells in percentage of the added radioactivity. Since both [125I]toxin and [12sI]- 
toxoid bound to some extent to the filters and since this effect was concentration dependent, 
the experiments were repeated without cells.  The obtained values were used to  transform 
filter-retained radioactivity into specific cell-bound radioactivity. The data were diagrammed 
according to Scatchard (18) where r/c is plotted against r using the function r/c  =  nK -- rK 
where r  represents the mean number of cholera protein molecules bound per cell;  c the free 
concentration of cholera protein; n  the mean number of molecules of cholera protein bound 
to the cell surface when it is saturated; K  the effective equilibrium constant for binding of 
cholera protein to the cell surface (the sort ml/molecule is converted to the more common 
liters/mol by multiplication with 6.02  X  102°). The equation is valid provided that the re- 
action is bimolecular, i.e. one cholera protein molecule binds only to one receptor site on the 
cell surface, which is an unproven assumption. Per cent dissociation of toxin and toxoid was 
studied after incubation of the labeled protein (100/zg/ml) with the thymocytes (5  >(  106 
cells/ml) at 37°C for 15 min. Mter centrifugation and washing twice, the ceils were again incu- 
bated in the MEM-BSA medium and portions of 100 #1, i.e.  1 X  106 cells, were filtered after 
various times through Millipore EAWP filters, and the retained radioactivity measured. 
Lymphocyte  Stimulation  Tests.--Mouse  thymocytes or  spleen cells  were  suspended  in 
MEM. The cells were washed once by centrifugation and suspended in RPMI  1640 medium 
(Grand Island Biological  Co., Grand Island, N. Y.)  supplemented with 10% human serum 
(Flow Laboratories Svenska AB, Solna,  Sweden), 100 IU/ml of penicillin and 100 #g/ml of 
streptomycin. The cell density was 5  X  106/ml.  200-#1 portions of the cell suspension were 
placed in the wells of Falcon Microtest II plates (Falcon Plastics, Div. of BioQuest, Oxnard, 
Calif.) and added with 10 #1 of conA, 100/zg/ml, or phytohemagglutinin (I)ifco Laboratories, 
Detroit, Mich.) diluted 1 : 10. Cholera toxin, toxoid, or toxin fractions as well as gangliosides, 
other glycosphingolipids  or antiserum were also added in volumes of 10 #1. Cultivation of the 
cells was performed at 37°C under a gas mixture consisting of 10% COs, 7% 02, and 83% N2. 
After 3 days, 2 #C of [3H]thymidine (The Radiochemical Centre) was added in a volume of 
10 gl. The cultivation was continued for another 18 h when the cells were harvested and placed 
on Millipore EAWP filters. Washing was performed with 2  X  10 ml of PBS,  10 ml of 5% 
trichloroacetic acid and 10 ml of 95% ethanol. The filters were then dried, dissolved in 1 ml 
of Soluene (Hewlett Packard Sverige AB, Bromma, Sweden) and radioactivity measured by 
scintillation counting in Permablend (Hewlett Packard Sverige)  dissolved in toluene. All ex- 
periments were performed in triplicates and results are expressed as mean values of one or 
several experiments. 
Cell Viability Tests.--Cell viability was evaluated with the trypan blue exclusion test (19). 
Demonstration  of  Mobility  of  Surface  Immunoglobulin  and  of  Cell-Bound  Toxin  ("Cap 
Formation").--For studies of surface immunoglobulin mobility a suspension of mouse spleen 
cells was prepared as described above for lymphocyte stimulation tests and the cell density 
adjusted to 2  X  l0  T cells/ml. To 100 #l of this suspension was added 100 #1 of rabbit anti- 
mouse immunoglobulin and the cells were incubated at 37°C for 30 rain. The cells were then 
washed twice with PBS containing 10 mM NaN3  to inhibit further membrane mobility (20). 
Mter suspension in 100 #1 of PBS the cells were incubated with 100 #l of FITC-labeled anti- 
rabbit immunoglobulin at room temperature for 15 min. Mter washing, the cells were mounted 
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For studies of cholera toxin receptor mobility, similarly prepared mouse thymus cells were 
incubated with cholera toxin, 2 ~g/ml, at 37°C for 15 min, washed, and incubated with rabbit 
anticholera toxin antiserum, diluted 1:4, 1:10 or 1:20 at 37°C  for another 30 min. The cells 
were then washed with PBS-NaN3,  and incubated with FITC-labeled antirabbit immuno- 
globulin and examined as described above. 
Skin Toxivity Assays.--The rabbit intradermal test of Craig (21) was used for determination 
of the skin toxic activity of cholera toxin and its derivatives. This assay measures the skin 
capillary permeability increasing ability of toxin and is visualized by the dermal deposition of 
intravenously injected blue dye. All dilutions were done with a borate-gelatin buffer, pH 7.5 
(3.1 g HsBO8,7.0 g NaC1,  2.0 g gelatin, H~O ad 1,000 ml), and each material was tested in 
three animals. The activity is expressed as number of blueing doses per nanogram of protein. 
RESULTS 
Interference of Cholera Toxin  and  Toxoid with Lymphocyte  Stimulation  and 
Lymphocyte  Viability.--Mouse  thymocytes were  cultured  in  the  presence of 
con A  and  the  degree of  stimulation  was  assayed  by measurements  of  the 
[SH]thymidine incorporation. The effect of cholera toxin  and  toxoid on  this 
stimulation was assayed after addition of varying amounts of these proteins 
to the cultures simultaneously with the con A. Fig. 1 shows the results of three 
different experiments, each performed in  triplicates.  Both  the  cholera toxin 
and the toxoid inhibited the lymphocyte stimulation  by con A but the  toxin 
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Fro.  1.  Effect of cholera toxin and of natural toxoid on thymocyte stimulation by con A. 
Each value is mean of  triplicate cultures and represents radioactivity of cell-incorporated 
[SHlthymidine in percentage  of  that of  cultures stimulated with con A  in  the absence of 
cholera protein. Subtraction of radioactivity of nonstimulated control cultures was done be- 
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was about 3G0 times more potent on a weight basis than the toxoid. The mean 
amounts  required  for half-maximal  inhibition  were  for  toxin  300 pg and  for 
toxoid 100 ng, i.e.  1.7  X  10  -11 mo!/liter and 9  N  10  -9 mol/liter,  respectively. 
Toxin caused complete inhibition  at  a  mean concentration of 5  X  10  -11  mol/ 
liter,  which corresponds to 10 bound molecules per cell. 
The effect of toxin on the stimulation of mouse spleen cells by phytohemag- 
glutinin was also determined.  Also in this instance  the toxin caused inhibition 
of  the  lectin-induced  stimulation;  600  pg  (3.4 X  10  -n  mol/liter)  gave  half- 
maximal inhibition. 
In order to study whether the inhibitory effect of toxin was due to cell death, 
the viability of thymocytes and spleen cells incubated with con A  in the pres- 
ence or absence of cholera toxin was determined by dye exclusion tests. There 
was only a very small increase of dead cells in the presence of toxin (Table I). 
TABLE I 
Trypan  Blue Exclusion  Test of the Influence of Cholera Toxin  on the  Viability  of Con 
A-Stimulated  Mouse  Thymus  and  Spleen  Cells 
Cells showing  staining with trypan blue 
Day of culture  Spleen cells  Thymus cells 
With toxin*  Without toxin  With toxin  Without toxin 
%  % 
1  18  16  35  24 
2  35  34  62  54 
3  38  33  72  68 
4  45  43  86  83 
* Concentration,  1 #g/ml. 
Binding Properties of Toxin and Toxoid to Lymphocytes.-- 
Immunofluorescence studies:  Mouse  thymocytes were incubated  with  chol- 
era  toxin or toxoid  and  thereafter  treated  with  rabbit  anticholera  toxin  and 
FITC-labeled  antirabbit  immunoglobulin  serum.  Binding  of  toxin  could  be 
demonstrated when the concentration of toxin was 100 ng/ml or more, and of 
toxoid when  the concentration was about the  same.  Two patterns  of binding 
were observed with both toxin and  toxoid  (Fig.  2).  The fluorescence was dis- 
tributed either  as a  continuous ring around the cell  (Fig. 2 a  and c) or as dis- 
crete areas on the cell (Fig. 2 b, d, and e). 
Mixing  toxin,  or toxoid,  1 #g/ml,  with  an equal  volume of the  gangiioside 
GM1, 100 ng/ml,  before  the  incubation  with  thymocytes resulted  in complete 
inhibition  of toxin or toxoid binding  as revealed  by immunofluorescence.  No 
binding of toxin to human red blood cells could be demonstrated by immuno- 
fluorescence. 
Studies  with  radioiodinated  toxin,  toxoid,  and con A:  It was assessed  that 
radioiodinated  toxin,  toxoid,  and  con  A  all  bound  to  mouse  lymphocytes. FIG.  2.  Binding of  cholera  toxin,  toxoid,  and  toxin subunits to  mouse  thymus cells  as 
demonstrated by immunofluorescence. Concentration of toxin and its derivatives was 1/~g/ml 
and incubation was carried out for 15 rain at room temperature.  (a) Binding of cholera toxin 
showing fluorescent surface-located rings. (b) Binding of cholera toxin showing surface-located 
fluorescent patches.  (c)  Binding of cholera toxoid showing fluorescent rings.  (d)  Binding of 
cholera toxoid showing fluorescent patches.  (e) Same as (d) but focus is on the upper surface 
of the cell.  (f) Binding of purified L subunit preparation showing weakly fluorescent patches. 
Purified H  subunit did not bind demonstrably.  X  2,5(]0. 
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Dilution  experiments where  the  labeled  and  unlabeled  toxin  was  mixed  in 
various proportions but the total toxin amount held constant, showed that the 
radioiodination  had  not  influenced  the  cell-binding  properties.  Nor  had  the 
labeling affected the skin toxic activity of the toxin. 
The binding properties of toxin to cells were studied in two experiments with 
different batches of  [125I]toxin. A  fixed concentration  of  ['25I]toxin,  50 ng/ml, 
was mixed with different concentrations of unlabeled toxin and incubated with 
lymphocytes for 30 rain. It was found that in the low concentration range toxin 
bound in constant proportions to the cells; in higher concentration, the binding 
of toxin to the cell surface became a  saturable process (Fig. 3 a). IC~0, i.e. the 
concentration  leading  to  half-maximal  inhibition  of  the  percentage-bound 
[~25I]toxin, was 400 ng/ml in one experiment and 550 ng/ml in the other one 
(4.8  X  10  -9  and  6.6  X  10-  9 mol/liter).  For more  detailed  evaluation  of  the 
data a curve was drawn from the mean values of the two  experiments  (dotted 
line, Fig. 3 a) and all points transcribed to a Scatchard plot (Fig. 3 b). From the 
latter  diagram  the  mean number of  toxin molecules bound  per  cell  (n)  was 
calculated  and  found  to  be 4  X  104  molecules/cell.  This  value was  also  ob- 
tained  from both of the original curves in  Fig.  3 a.  The association constant 
Ka was 7 X  108 liters/mol when calculated from the averaged curve (Fig. 3 b), 
and 3  X  108 and 1 X  109 liters/mol in the individual experiments. 
A  similar  study  was  done  with  the  cholera  toxoid  (Fig.  3 c  and  d).  IC50 
ranged  from 200  to  280  ng/ml  (3.6  X  10-  9 to  4.9 X  10  -9  mol/liter),  n  was 
found to be 4  X  104 molecules/cell which agrees with  the value of the  toxin, 
and Ka between I  X  109 and 7 X  109 liters/tool (mean 4  X  109 liters/tool). 
The  association  experiment  with  toxin  and  lymphocytes was  repeated  at 
+5°C  under  otherwise  identical  conditions.  The  temperature  difference  did 
not significantly change the binding pattern of toxin which shows that meta- 
bolic events probably do not influence on the extent of binding. The same was 
found for toxoid. 
In order to see whether the fraction of [~25I]toxin which remains in the super- 
nate had different cell-binding properties than the fraction which had bound to 
the cells,  1/zg 125I-toxin was incubated with  108 cells in  10 ml MEM-BSA for 
15 rain at 5°C. After centrifugation the medium which still contained 94% of 
the  [125I]toxin was mixed in portions with various amounts of unlabeled  toxin 
and tested for binding to thymus cells as previously. The binding curves were 
almost identical  to  those  obtained in  the  experiments shown  in  Fig.  3 a  and 
b. The same experiment with toxoid gave results very similar to those in  Fig. 
3 c and d. 
The  kinetic  of  the  binding  to  thymocytes was very similar for  [~25I]toxin 
and [12~I]toxoid (Fig. 4). A very rapid binding was observed, with both proteins 
being complete within 5 min at 37°C. 
When  bound  to  the  lymphocytes  the  dissociation  tendency  of  both  toxin 
and toxoid was very small. Less than  1% of the radioactivity was lost  during 
incubation up to 1 h from l}anphocytes saturated with [~25I]toxin or [l"~I]toxoid. J.  HOLMGREN~  L.  LINDHOLM~  AND  I.  LONNROTH  809 
20- 
= 
===. lo 
_g 
i 
Q  ['~°l]toxin + unlabeled  toxin 
0  0.05  0.5  5  50 
TOTAL CHOLERA  PROTEIN CONCENTRATION,  119/ml 
40 
30 
2o 
U 
10 
~  KA~ (7 +-  4Ix 10  0 liters/tool  e 
"\,, 
"\ 
•  o 
i  i  i  l  i 
10  20  30  40  50 
r  1103  molecules/cell) 
E 
..= 
S. 
| 
== 
#., 
¢.3 
20- 
10- 
12Sl]  toxoid +ualabel ed toxoid 
o.,, 
x  ,/ 
, 
'1/  '  50  0  0.05  0.5  5 
TOTAL CHOLERA PROTEIN CONCENTRATION,  pg/ml 
E 
~J 
4O 
d 
30 
20- 
10- 
k  K~=(4+-3)x109  liters/tool e 
,  i  i  i  i  |  i 
10  2O  3O  40  50 
r  |lOS molecules/ceil) 
Fro. 3.  Binding properties of toxin and toxoid to thymocytes. (a) Cell-bound radioactivity 
as a function of total concentration of added unlabeled toxin and [z25I]toxin. (©--©), experi- 
ment 1;  (O--O), experiment 2;  (---), average curve drawn from  experiment i  and 2.  (b) 
Scatchard plot of the average curve in (a),  (n =  the mean number of molecules bound to a 
cell saturated with toxin; KA =  the association constant). (c) and (d) correspond  to (a) and 
(b) using unlabeled toxoid and [l~]toxoid. 
In order to investigate whether  the cholera toxin is competing with con A 
for the same cellular binding sites, 100 ng of [125I]con A was mixed with various 
amounts of unlabeled toxin or con A,  and incubated with  the  thymocytes at 
37°C  for 30 rain. Table II shows the results. The nonlabeled con A  prevented 
the binding of [z25I]con A  whereas the cholera toxin did not affect the cellular 
binding of [12SI]con A. 
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FIG. 4.  Cell-bound [125I]toxin and  [l~sI]toxoid as  a  function  of  the incubation time. A 
vholera protein concentration of 50 ng/ml was used, and incubation  performed at 37 ° C. 
TABLE II 
Study  of Possible Competition between Con A  and Cholera Toxin in Binding  to Mouse Thymus 
Lymphocytes 
Competing protein  Cell-bound [1~I]Con A* 
ug  ~,mol/l  % 
--  0  0  15.8 
Con A  0.2  0.01  17.5 
ConA  2  0.11  12.4 
Con A  20  1.11  2.8 
Cholera toxin  2  0.12  16.7 
Cholera toxin  20  1.19  16.6 
* Mean of triplicates; [125I]con A was tested in an amount of 0.1/~g. 
formation":  Surface  immunoglobulin was  demonstrated  on  mouse  spleen 
cells  by means  of  immunofluorescence. It  could  be  found that  the  surface 
immunoglobulin was localized to  one pool  of  the  cell on about 85 % of cells, 
when the cells  had  been incubated with  antimouse immunoglobulin serum. 
This "cap-formation" was not significantly affected by preincubating the cells 
with either cholera toxin or toxoid at a  concentration of  1 #g/ml for 30 rain 
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TABLE III 
Influence of Cholera Toxin and Toxoid on Cap Formation of Surface Immunoglobulin on Mouse 
Spleen Cells 
Pletreatment  Cells  showing caps 
% 
--  84 
I00 ng cholera toxin  82 
100 ng cholera toxoid  83 
Attempts  were  also  done  to  demonstrate  cap-formation  of  cholera  toxin 
bound to thymocytes. It was found that cells preincubated with toxin and then 
with rabbit antitoxin diluted 1:4,  1:10, or 1:20, showed caps after treatment 
with antirabbit immunoglobulin only in 6, 5, and 8 % for the different antiserum 
dilutions. Thus it seems that the mobility of the thymocyte receptors for toxin 
is more restricted than the mobility of spleen cell surface immunoglobulin. 
Effect  of  GangIiosides  and  Antiserum  in  Lymphocyte  Stimulation  Tests.- 
Mouse thymocytes were cultured in the presence of con A  and an inhibitory 
amount,  10 ng, of cholera toxin. Different pure gangliosides or related neutral 
glycosphingolipids were  added  in varying amounts  at  the  same  time  as  the 
toxin, and the degree of lymphocyte stimulation determined by measurements 
of [3H]thymidine incorporation. The results are found in Table IV. The only 
glycosphingolipid  which  blocked  the  inhibitory  effect  of  cholera  toxin  on 
lymphocyte stimulation was the GM1 ganglioside which was effective in amounts 
equal  to  or above the  amount of toxin present.  In  similar  experiments also 
antiserum  to  cholera  toxin  blocked  the  lymphocyte  stimulation  inhibitory 
action of the toxin (Table IV). 
It  was  controlled that  the  GM1 ganglioside  and  the  antiserum  to  cholera 
toxin in the effective concentrations did not per se affect the stimulatory power 
of con A on lymphocytes. It was also assessed that a-methyl-D-glucoside, the 
inhibitor of con A, and con A itself had no effect on the skin activity of cholera 
toxin even when tested in high concentrations. 
Binding of Cholera  Toxin Subunits to  Thymocytes  and Effect  of Subunits on 
Lymphocyte  Stimulation.--Binding  of  purified  L  and  H  subunits  to  mouse 
thymocytes was  studied  by immunofluorescence. The L  subunit  was  found 
to bind to thymocytes when  applied to the cells in concentrations of 1/zg/ml 
or more (Fig. 2f). Binding of purified H could not be demonstrated by immuno- 
fluorescence. 
The effect of the purified L and H subunits (fractions H and L) on thymocyte 
stimulation by con A was studied and compared with the effect of toxin frac- 
tions containing both subunits in different proportions (fractions 28 and 31). 
The separated subunits were much less potent in inhibiting the lymphocyte 
stimulation than the fractions containing both subunits  (Fig.  5).  In general, 
the  capacity of  the  cholera toxin  and  its  derivatives  to inhibit  lymphocyte 
stimulation  correlated with  the  skin  toxic  activity  of  the  proteins.  This  is 812  INTERACTION  OF CHOLERA TOXIN WITH LYMPHOCYTES 
TABLE IV 
Influence of Gangliosides, Neutral Glycosphingolipids, and Antitoxin A ntiserum on the Inhibitory 
Effect  of  Cholera  Toxin  on  Con  A-Induced  Thymocyte  Stimulation* 
Test substance  Amount  Decrease of the inhibition  caused by toxins 
ng  % 
GM1  100  100 
10  100 
l  2 
0.1  0 
GDla  100  15 
10  0 
1  0 
GA1  100  10 
10  0 
1  0 
G-D1  b  100  0 
G-r  100  0 
GM2  100  0 
G~3  100  0 
G~ 3-NGN  100  0 
Tetrahexoside-GlcNAc  100  0 
Globoside  100  0 
Antitoxin  Dilution 
1:200  100 
1:2,000  100 
1:20,000  12 
* 1 X  106 cells, 1/~g of con A and 10 ng of toxin; total volume 0.2 ml. 
Mean of three to nine cultures. 
shown in Table V, where it is also seen that the biologic activity of the toxin 
fractions containing both H  and L  subunit  material is similar to  that  of the 
intact toxin, whereas the activity of the separated subunits is more like that of 
the toxoid. 
DISCUSSION 
This study shows,  as does a  parallel study by Sultzer and Craig (22),  that 
cholera toxin can inhibit mouse lymphocytes from being stimulated  to DNA 
synthesis by mitogenic lectins. It further shows that the capacity of toxin and 
toxin derivatives to inhibit lymphocyte stimulation corresponded well to their 
activity in the skin test which is documented to reflect the choleragenic action 
of the toxin. The GMI ganglioside specifically inhibited the toxin effect on lym- 
phocytes, as it has previously done  with the effect in skin,  gut,  and fat cells 
(10-13). In the light of the c-AMP increasing effect of cholera toxin on lympho- 
cytes,  it seems that  the lymphocyte adds  to  the variety of target cells upon 
which the common key action of cholera toxin is activation of adenylate cyclase. 5.  HOLMGREN~  L,  LINDHOLM~  AND  I.  LONNROTH  813 
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FIG. 5.  Effect on con A-induced thymocyte stimulation of purified toxin subunits (L and 
H) and of toxin fractions containing both L and H subunits in different proportions (L >  H  = 
fraction 31, and L  <  H  =  fraction 28).  Each value is mean of three to six cultures, and is 
calculated as described in the legend to Fig.  1. 
TABLE  V 
Comparison of Skin Toxicity and Lymphocyte-Stimulation Inhibitory Activity of Chdera Toxin 
and Toxin Derivatives 
Lymphocyte  stimulation-  Cholera protein  Subunit percent*  Skin blueing doses  inhibitory doses per 
H  L  per nanogram~  nanogram§ 
Toxin  33  67  4.4  3.3 
Toxoid  0  100  0.005  0.01 
Frac, H  100  0  0.1  0.1 
Frac. 28  73.0  27.0  2.5  2.0 
Fray. 29  36.5  63.5  7.5  N.D.II 
Frac. 30  10.0  90.0  9.3  N,D. 
Frac. 31  1.6  98.4  5.1  12.5 
Frac. 32  0.8  99.2  2.8  N.D. 
Fray. L  (33)  (0)  100  1.0  0.3 
Frac. 34  0  100  0.6  N.D. 
* Densitometric determination of protein-stained SDS  electrophoresis plates,  and quali- 
tative control by immtmodiffusion; parentheses indicate positive gel-precipitation reaction 
where densitometry was negative. 
Mean of 8-12 values in three rabbits tested over a 6-too period. 
§ Mean of six  or  nine  values for  half-maximal inhibition of  con  A-induced thymocyte 
stimulation determined in two or three separate experiments. 
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The outcome of this activation is determined  by the cell type and not by the 
toxin.  This  explains  why  toxin-treated  fat  cells  release  lipid  (23), liver  cells 
convert glycogen into glucose (24), adrenal cells produce steroid hormone (25), 
and lymphocytes can no longer be stimulated by con A, etc. 
We were particularly interested in using the lymphocytes to test how the cell-bind- 
ing properties relate to the biologic action of the toxin, and what significance  the two 
types of subunits, H  and L, have for binding and activity. We found by immuno- 
fluorescence tests  that  toxin, which probably consists of one H  and  six  or seven  L 
subunits,  and a  natural toxoid consisting exclusively of aggregated L  subunits,  both 
bound well to the surface of lymphocytes; purified L  subunits also showed binding 
but purified H  subunit did not. These findings infer that the cell-binding property of 
the toxin resides in the L type of subunit, and that the nontoxicity of the toxoid can- 
not be explained as an inability to bind to the target cells. However, it required more 
quantitative  experiments with radioactive toxin and toxoid to clarify whether  there 
exist differences  between the proteins with regard to binding kinetics, binding strength 
or number of molecules that could bind to a single  cell. We found no such difference 
to the advantage of toxin. Approximately 40,000  molecules of either protein  could 
maximally bind  to a  single cell.  The kinetics  of the binding was identical and  the 
affinity was not significantly different; in fact it tended to be higher for toxoid than 
for toxin, KA being 7 4- 4  X  108 and 4  4- 3  X  10  ° liters per mole respectively. These 
data for the binding properties of toxin to thymus cells agree with those recently pub- 
lished  by Cuatrecasas  for binding  to fat  cells.  A  single  fat  cell  could  bind  20,000 
molecules of cholera toxin, and the dissociation constant was estimated to 4.6 X  10  -2° 
mols/liter  (26).  It seems documented by these results  that toxoid binds equally as 
well as toxin to the cells. Additionally, the data suggest that the maiority of molecules 
of both proteins bind with the same number of combining sites to the cell surface. In 
the low concentration range the binding curves for both toxin and toxoid flattened 
out in a characteristic manner. The explanation for this binding pattern is presently 
unknown, but might be elucidated by detailed quantitative studies between cholera 
toxin or toxoid and solid phase pure GM1 ganglioside which are in progress. However, 
the present study revealed that (a)  the labeled and unlabeled cholera proteins bind 
equally well  to the lymphocytes; (b)  when attached  to the cells,  very little  cholera 
toxin or toxoid dissociates into the medium; and (c) the bound and unbound fractions 
of the cholera proteins have similar binding properties to cells, since a toxin or toxoid 
solution which had been partially absorbed with cells, had the same binding proper- 
ties as the original solution. 
The  capacity  to  inhibit  lectin-induced  lymphocyte  activation  seemed  to 
involve the presence of not only L but also H  subunit. Thus the purified H  and 
L  subunits  of toxin were much less active  than  fractions of toxin containing 
both subunits;  it is very possible  that  the slight  activity in the purified  sub- 
unit preparations was due to trace contamination with the other subunit.  This 
pattern  was also seen in skin  tests,  thereby confirming our observations in a 
previous  study  (14).  Finally,  preliminary  experiments  indicate  that  whereas 
fractions containing both H  and L  subunits  raise  the  c-AMP levels much in J.  HOLMGREN, L.  LINDHOLM, AND  I.  L()NN'ROTH  8i5 
lymphocytes, the  separated  subunits  are almost inactive3 The proposal in  a 
previous report that for skin toxic activity both H  and L subunits are important 
(14) therefore seems valid also in the employed in vitro systems using lympho- 
cytes. 
The view is reasonable that it is the difference in subunit composition which 
causes the difference in biologic activity between toxin and toxoid.  One func- 
tion  of the L  subunit  is probably as indicated  by this  and previous studies 
(11) 3 to confer binding of the toxin to cell surface GM1 receptors. We have re- 
cently shown  that it is the  oligosaccharide portion with its single  sialic  acid 
which is probably the initial binding site of GM1, but at least for in vitro fixation 
the  sphingosine  portion  also  seems  important,  probably  by  stabilizing  the 
initial binding between the toxin and the ganglioside (27). 
The role of the H  subunit is not known. Apparently it does not bind to the 
surface provided that the purified preparation tested by us was representative, 
and it does not seem to make the toxin better binding than toxoid to cell mem- 
branes.  This  does not  exclude  that  membrane  structures  could  exist  which 
become  accessible  for  the  H  subunit  through  rearrangements  of  membrane 
architecture after the attachment of the toxin to the cell surface. Since the H 
subunit seems to be important for the toxin action it is possible that this sub- 
unit, directly or via an intermediary reaction, represents the adenylate cyc[ase- 
activating portion  of the toxin. Obviously, more information is required,  e.g. 
of possible effects on both membrane and toxin structure which may be caused 
by the formation of the toxin-GM1  ganglioside complex, before it is meaningful 
to  discuss  how  this  activation  could  occur.  However,  the  concept  that  one 
portion of a  bacterial  toxin is responsible for avid binding  to cell membrane 
receptors, whereas a  different portion exerts the direct action on cell metabo- 
lism, is not unique for cholera toxin. A similar hypothesis has been formulated 
for diphtheria  toxin  (28),  and  recent  observations also  suggest  a  distinction 
between "binding" and "toxic" sites for tetanus toxin (29, 30). 
The observations in this study and in the report of Sultzer and Craig (22) that 
inhibition of lectin-induced  stimulation by cholera toxin concerns  thymus as well as 
spleen  cells,  and  the mitogens con A, phytohemagglufinin and lipopolysaccharide, 
indicate that cholera toxin can interfere with DNA synthesis in T cells aswell as B cells. 
They also suggest that the toxin does not compete with the surface receptors for the 
lectins; this was directly proven with radiolabeled con A which bound equally well to 
lymphocytes when toxin was present as when it was absent. It was also evident that 
the toxin does not exert the inhibitory effect by decreasing  cell viability, nor does 
toxin react directly with con A. An interesting observation is that cholera toxin did 
not affect cap formation of immunoglobulin receptors on the surface of spleen  cells 
when the cells were treated with anti-immunoglobulin antiserum. This indicates that 
4LSnnroth,  I., J.  Holmgren, and  C. Norrman.  Interaction  of cholera toxin and  toxin 
derivatives with lymphocytes. II. Effect on intracellular cyclic AMP levels. Manuscript in 
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receptor mobility was not generally disturbed  in lymphocytes to which  toxin had 
bound. It may therefore be suggested that the toxin mediates its effect on the cells 
without interfering with the mobility of the lectin receptors or with the ability of the 
lectins to induce cap formation. It seems that toxin does not affect the events in lectin- 
induced lymphocyte activation which take place on the cell surface,  but a later more 
central step as yet unrecognized.  This is the more likely as the natural cholera toxoid 
tested had no effect on the stimulation despite it had almost identical binding proper- 
ties as toxin to the cells. The known ability of cholera toxin but not toxoid to activate 
adenyl cyclase and thereby raise the intracellular levels  of c-AMP in various cells, 
including  lymphocytes, suggests  that the step interfered with may be regulated, di- 
rectly or indirectly, by c-AMP. The effect could relate to the observation that phos- 
phorylation of histones by protein kinases in lymphocytes is regulated by c-AMP (31) 
This work documents that studies of interaction between lymphocytes and 
cholera toxin may be of interest to elucidate important aspects of the mecha- 
nism  of action  of  the  toxin,  as  well  as  factors which  control  lectin-induced 
lymphocyte stimulation.  They may also  have relevance for certain  immune 
functions  of lymphocytes, since  cholera  toxin  has  been  reported  to  decrease 
lymphocyte-mediated in vitro destruction of allogeneic cells (8, 9) and to have 
an  adjuvant  action  on humoral  antibody formation in vivo  (32). 
SUMMARY 
The interaction of cholera toxin and a number of toxin derivatives, contain- 
ing different proportions of light and heavy toxin-composing subunits (L and 
H), with mouse lymphocytes was studied. Experiments with [t~sI]toxin showed 
that a  single cell can rapidly, within minutes,  bind up to 40,000 molecules of 
toxin,  the association constant was estimated to 7 -4- 4  ><  108 liters/mol,  and 
binding  was found  to be very similar at 37°C  and 5°C.  Immunofluorescence 
studies revealed that the toxin attachment is located on the cell surface, and 
that purified L  subunit but not H  subunit binds to the cells.  A natural cholera 
toxoid,  built  up by aggregated L  subunits,  showed  almost identical  binding 
properties as toxin to the cells.  Pure GM1 ganglioside, the proposed membrane 
receptor  structure  for  toxin,  prevented  entirely  the  cellular  binding  of both 
toxin and toxoid. 
Cholera toxin in concentrations down to approximately 5  X  10--"  mol/liter 
(corresponding to 10 bound molecules/cell) inhibited thymus cells from being 
stimulated  to  DNA  synthesis  by  concanavalin  A  (con  A),  and  spleen  cells 
from such stimulation by phytohemagglutinin. The GM1 ganglioside but not a 
series of other pure structurally related gangliosides and neutral glycosphingo- 
lipids  neutralized  this  toxin  activity.  Toxin  derivatives  which,  in  similarity 
with toxin, possessed H  as well as L  subunits  but in other proportions, were 
potent inhibitors of con A-induced thymocyte stimulation, whereas the natural 
toxoid (aggregated L  subunits), purified toxin L  subunit and purified toxin H 
subunit were up to 300-fold less active on a  weight basis. The capacity of chol- J.  HOL~GREN,  L.  LINDHOLM,  AND  I.  LONNROTH  817 
era proteins  to inhibit  con A-induced  thymocyte stimulation  correlated well 
with  their  activity in  the  rabbit  intradermal  toxicity  assay. 
The inhibitory action of cholera toxin on con A-induced thymocyte stimula- 
tion did not depend on decreased cell viability from the toxin treatment, nor 
was it caused by a reaction between toxin and con A. [l~SI]con A bound equally 
well to the cells when toxin was present as when  it was  absent,  which  proves 
that the toxin did not compete for cellular con A  receptors. Nor did the toxin 
seem to disturb the general mobility of membrane receptors or their ability to 
accumulate in caps. 
It is concluded that the L  type of subunit confers rapid and firm binding of 
cholera toxin to lymphocyte membranes, probably to GM1 ganglioside receptors. 
For biologic activity the  additional presence of H  subunit  is important.  One 
manifestation  of  toxin  action  on  lymphocytes is  inhibition  of  lectin-induced 
DNA synthesis; probably this effect relates to the ability of cholera toxin to 
raise the levels of intracellular cyclic 3'5t-adenosine monophosphate. 
The authors wish to expresss their thanks  to Christina Norrman for valuable technical 
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